Sign in
4

Changes in Ownership

Sana Biotechnology, Inc. Filed Acc 0001562180-24-002476

Options or other derivatives

  • EVP, Chief Financial Officer acquired 368,958 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hardy Nathan · EVP, Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-07 Grant or award : show line 1 in the form Restricted Stock Units +67,083 67,083 D
2024-03-07 Grant or award : show line 2 in the form Stock Option (Right to Buy) +301,875 301,875 D
Loading xslF345X05/primarydocument.xml…